Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

XGN

Exagen Inc

Dec 26 • 02:23PM ET

4.89

Dollar change -0.12
Percentage change -2.49	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN BGNE MYGN QGEN NTRA GH VCYT CDNA PRPO FLGT

| Held by: VTI VXF DFAC DFSU DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.94	Insider Own	50.12%	Shs Outstand	17.52M	Perf Week	-11.32%
Market Cap	86.34M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	-1.68%	Shs Float	8.80M	Perf Month	20.86%
Income	-16.93M	PEG	-	EPS next Q	-0.26	Inst Own	36.26%	Short Float	0.89%	Perf Quarter	55.89%
Sales	55.75M	P/S	1.55	EPS this Y	33.30%	Inst Trans	-4.59%	Short Ratio	0.94	Perf Half Y	164.59%
Book/sh	0.73	P/B	6.66	EPS next Y	25.45%	ROA	-32.39%	Short Interest	0.08M	Perf Year	175.00%
Cash/sh	1.25	P/C	3.92	EPS next 5Y	-	ROE	-83.86%	52W Range	1.30 - 6.22	Perf YTD	145.98%
Dividend Est.	-	P/FCF	-	EPS past 5Y	2.69%	ROI	-48.86%	52W High	-21.30%	Beta	1.43
Dividend TTM	-	Quick Ratio	3.72	Sales past 5Y	10.63%	Gross Margin	58.80%	52W Low	276.45%	ATR (14)	0.51
Dividend Ex-Date	-	Current Ratio	4.05	EPS Y/Y TTM	49.65%	Oper. Margin	-27.62%	RSI (14)	54.44	Volatility	13.27% 11.02%
Employees	179	Debt/Eq	1.83	Sales Y/Y TTM	8.00%	Profit Margin	-30.36%	Recom	1.33	Target Price	6.25
Option/Short	Yes / Yes	LT Debt/Eq	1.69	EPS Q/Q	10.03%	Payout	-	Rel Volume	0.76	Prev Close	5.02
Sales Surprise	-7.85%	EPS Surprise	3.38%	Sales Q/Q	-6.78%	Earnings	Nov 12 BMO	Avg Volume	83.27K	Price	4.89
SMA20	0.44%	SMA50	31.21%	SMA200	92.25%	Trades		Volume	48,293	Change	-2.49%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Oct-15-21	Resumed	Cowen	Outperform	$26
Apr-15-21	Initiated	Canaccord Genuity	Buy	$25
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$32
Oct-08-20	Initiated	BTIG Research	Buy	$18
Jun-02-20	Resumed	Cantor Fitzgerald	Overweight	$19 → $20
Oct-14-19	Initiated	William Blair	Outperform
Oct-14-19	Initiated	Cowen	Outperform	$17
Oct-14-19	Initiated	Cantor Fitzgerald	Overweight	$18

Dec-12-24 09:00AM	Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE CTD (GlobeNewswire) +12.02%
Nov-14-24 04:30PM	Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE CTD Platform (GlobeNewswire) +5.45%
Nov-13-24 04:05PM	Exagen Inc. to Participate in Fourth Quarter Investor Conferences (GlobeNewswire)
02:09AM	Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com)
12:51AM	Q3 2024 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
09:25AM	Loading…
Nov-12-24 09:25AM	Exagen Inc. (XGN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -6.06%
Nov-11-24 07:25AM	Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-29-24 04:05PM	Exagen to Announce Third Quarter 2024 Results on November 12, 2024 (GlobeNewswire)
Oct-21-24 04:05PM	Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence (GlobeNewswire)
Sep-04-24 04:05PM	Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference (GlobeNewswire) +15.93%
Aug-29-24 09:55AM	Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now (Zacks)
Aug-26-24 08:50AM	Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Aug-09-24 09:15AM	Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out? (Zacks) +22.46%
Aug-08-24 08:50AM	Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain (Zacks) +12.65%
Aug-05-24 12:53PM	XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +17.65%
09:10AM	Loading…
09:10AM	Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance (GlobeNewswire)
Aug-02-24 09:00AM	Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Aug-01-24 09:00AM	Exagen Appoints Jeffrey G. Black as New Chief Financial Officer (GlobeNewswire)
Jul-22-24 09:00AM	Exagen to Announce Second Quarter 2024 Results on August 5, 2024 (GlobeNewswire)
Jun-13-24 08:50AM	Why Fast-paced Mover Exagen (XGN) Is a Great Choice for Value Investors (Zacks)
May-15-24 05:01AM	Exagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ... (GuruFocus.com) +8.52%
May-13-24 12:53PM	XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:10AM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year (GlobeNewswire)
May-06-24 04:05PM	Exagen Announces Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-30-24 04:05PM	Exagen to Announce First Quarter 2024 Results on May 13, 2024 (GlobeNewswire)
Apr-26-24 08:30AM	Exagen Inc. Announces Changes to the Board of Directors (GlobeNewswire)
Mar-19-24 09:37AM	Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript (Insider Monkey) -12.99%
01:55AM	Q4 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
12:52PM	Loading…
Mar-18-24 12:52PM	XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +9.26%
09:25AM	Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Mar-08-24 09:00AM	Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (GlobeNewswire)
Mar-07-24 04:05PM	Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024 (GlobeNewswire)
Feb-06-24 08:50AM	Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock (Zacks)
Jan-30-24 04:05PM	Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -6.52%
Jan-07-24 12:00PM	Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance (GlobeNewswire)
Nov-13-23 04:05PM	Exagen Inc. Reports Strong Third Quarter 2023 Results (GlobeNewswire) +16.44%
Nov-09-23 04:05PM	Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers (GlobeNewswire) -6.25%
Nov-02-23 04:05PM	Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Oct-30-23 04:05PM	Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire) +6.75% +6.08%
Sep-28-23 04:05PM	Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting (GlobeNewswire)
Sep-12-23 04:05PM	Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Aug-09-23 10:47AM	Exagen Inc. (NASDAQ:XGN) Q2 2023 Earnings Call Transcript (Insider Monkey) -7.22%
Aug-08-23 04:13AM	Q2 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 09:15AM	Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.76%
08:00AM	Exagen Inc. Reports Strong Second Quarter 2023 Results (GlobeNewswire)
Jul-26-23 04:05PM	Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-25-23 04:05PM	Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire) -6.51%
Jul-24-23 04:05PM	Exagen Inc. Appoints Paul Kim to Board of Directors (GlobeNewswire)
07:33AM	This Exagen Insider Increased Their Holding In The Last Year (Simply Wall St.)
Jun-13-23 08:19AM	Exagen Inc.'s (NASDAQ:XGN) Low P/S No Reason For Excitement (Simply Wall St.) -8.36%
May-30-23 09:00AM	Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
May-17-23 07:11AM	Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three years (Simply Wall St.) -6.90%
May-16-23 11:03AM	Q1 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents) +19.51%
May-15-23 05:55PM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Exagen Inc. Reports First Quarter 2023 Results (GlobeNewswire)
May-01-23 04:05PM	Exagen Announces Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-24-23 04:05PM	Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Mar-24-23 08:16AM	Exagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 06:12AM	Exagen Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Mar-21-23 07:40AM	Q4 2022 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-23 05:25PM	Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results (GlobeNewswire)
Mar-06-23 04:05PM	Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023 (GlobeNewswire) +5.31%
Feb-27-23 09:00AM	Exagen Inc. to Participate in Upcoming March Conferences (GlobeNewswire)
Feb-14-23 06:19AM	Exagen Inc. (NASDAQ:XGN) insider upped their holding earlier this year (Simply Wall St.)
Jan-30-23 04:05PM	Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-23-23 09:00AM	Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors (GlobeNewswire)
Nov-14-22 07:55PM	Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.49% +42.38%
04:05PM	Exagen Inc. Reports Third Quarter 2022 Results (GlobeNewswire)
Nov-08-22 04:05PM	Exagen Inc. to Participate in Fourth Quarter Investor Conferences (GlobeNewswire)
Oct-31-22 04:05PM	Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022 (GlobeNewswire)
Oct-17-22 09:00AM	Exagen Announces Appointment of John Aballi as CEO (GlobeNewswire)
Oct-04-22 08:25AM	Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer (GlobeNewswire)
Sep-20-22 04:05PM	Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting (GlobeNewswire) -10.02%
Sep-19-22 10:20AM	The past three years for Exagen (NASDAQ:XGN) investors has not been profitable (Simply Wall St.) -8.67%
Sep-01-22 04:05PM	Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients (GlobeNewswire)
Aug-05-22 12:00PM	Exagen Inc. (XGN) Q2 2022 Earnings Call Transcript (Motley Fool) -23.61%
Aug-04-22 06:55PM	Exagen Inc. (XGN) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:06PM	Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA (GlobeNewswire)
04:05PM	Exagen Inc. Reports Second Quarter 2022 Results (GlobeNewswire)
Jul-25-22 04:05PM	Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire) +8.23% -6.11%
Jul-21-22 04:05PM	Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022 (GlobeNewswire)
Jul-05-22 08:25AM	Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility (GlobeNewswire)
Jun-21-22 08:10AM	Does Exagen (NASDAQ:XGN) Have A Healthy Balance Sheet? (Simply Wall St.) +8.65%
Jun-09-22 08:25AM	Exagen Inc. Expands Coverage with MediNcrease (GlobeNewswire) +10.78%
May-26-22 04:05PM	Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference (GlobeNewswire) +9.50%
May-16-22 04:05PM	Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus (GlobeNewswire)
May-11-22 05:55PM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -16.16%
04:06PM	Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test (GlobeNewswire)
04:05PM	Exagen Inc. Reports First Quarter 2022 Results (GlobeNewswire)
May-10-22 10:45AM	AdaptHealth Corp. (AHCO) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +10.25%
May-03-22 05:15PM	MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +9.25%
May-01-22 12:00PM	Exagen Announces Five-Week Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-25-22 04:05PM	Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022 (GlobeNewswire)
Apr-20-22 04:05PM	Exagen Inc. to Participate in Investor Summit Groups Q2 Conference (GlobeNewswire) -5.64%
Apr-12-22 07:22AM	Shareholders in Exagen (NASDAQ:XGN) have lost 61%, as stock drops 15% this past week (Simply Wall St.)
Mar-30-22 08:25AM	Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems (GlobeNewswire)

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
NMSIC Co-Investment Fund, L.P.	10% Owner	Nov 20 '24	Sale	3.30	200,000	660,040	2,108,958	Nov 27 04:18 PM
Black Jeffrey G.	Chief Financial Officer	Nov 15 '24	Buy	2.98	22,298	66,448	274,492	Nov 19 07:24 PM
ABALLI JOHN	President and CEO	Nov 14 '24	Buy	2.81	24,305	68,297	689,799	Nov 18 06:32 PM
Adawi Kamal	Officer	Oct 08 '24	Proposed Sale	2.94	84,162	247,436		Oct 08 04:39 PM
Adawi Kamal	Officer	Aug 09 '24	Proposed Sale	2.76	52,624	145,242		Aug 09 05:08 PM
ABALLI JOHN	President and CEO	May 16 '24	Buy	1.92	40,401	77,570	40,401	May 16 08:02 PM
Adawi Kamal	CFO and Corporate Secretary	Mar 04 '24	Sale	1.91	12,784	24,407	243,749	Mar 06 04:05 PM
Adawi Kamal	CFO and Corporate Secretary	Feb 06 '24	Sale	1.95	6,738	13,133	181,533	Feb 08 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XGN

Exagen Inc

Upgrade your FINVIZ experience